SHL.DE XETRA
Siemens Healthineers AG
1W: +0.2%
1M: -2.5%
3M: +7.4%
YTD: -7.3%
1Y: -19.8%
3Y: -14.3%
5Y: -28.8%
€37.86 ($42.37)
+0.25 (+0.66%)
Weekly Expected Move ±2.6%
€36
€37
€38
€39
€40
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$3.1B
+24.9% ▲
5Y CAGR: +11.3%
Capital Expenditures
$818M
-17.5% ▼
5Y CAGR: +8.0%
Free Cash Flow
$2.3B
+27.7% ▲
5Y CAGR: +12.7%
Dividends Paid
$1.1B
-0.3% ▼
Buybacks
$301M
-2910.0% ▼
Net Change in Cash
-$508M
-148.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.7B | $2.0B | $1.5B | $1.9B | $2.1B |
| Depreciation & Amort. | $1.0B | $1.3B | $1.6B | $1.2B | $1.3B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $53M | -$1.1B | -$842M | -$605M | -$581M |
| Other Non-Cash Items | $50M | $267M | -$150M | $113M | $525M |
| Operating Cash Flow | $2.8B | $2.3B | $1.8B | $2.5B | $3.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$674M | -$852M | -$838M | -$696M | -$818M |
| Acquisitions (Net) | -$13.5B | -$14M | -$224M | $34M | -$86M |
| Investment Purchases | -$12M | -$2M | -$7M | -$4M | -$2M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$14.1B | -$868M | -$1.1B | -$666M | -$906M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$155M | -$114M | $1.1B | -$211M | -$1.2B |
| Stock Repurchased | -$255M | -$309M | -$421M | -$10M | -$301M |
| Dividends Paid | -$856M | -$955M | -$1.1B | -$1.1B | -$1.1B |
| Other Financing | $10.9B | -$19M | -$15M | -$16M | -$25M |
| Financing Cash Flow | $12.0B | -$1.4B | -$380M | -$1.3B | -$2.6B |
| Net Change in Cash | $666M | $114M | $206M | $1.0B | -$508M |
| Cash End of Period | $1.3B | $1.4B | $1.6B | $2.7B | $2.2B |
| Free Cash Flow | $2.1B | $1.4B | $971M | $1.8B | $2.3B |